Does Rallies show BIIB price targets?

Yes. Rallies tracks BIIB analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.

Is BIIB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BIIB. It does not provide personalized investment advice.

BIIB (Biogen) Stock Analysis - Analyst Ratings

Biogen (BIIB) is a publicly traded Healthcare sector company. As of May 20, 2026, BIIB trades at $187.75 with a market cap of $28.33B and a P/E ratio of 20.20. BIIB moved -1.35% today. Year to date, BIIB is +7.16%; over the trailing twelve months it is +47.22%. Its 52-week range spans $110.04 to $205.97. Analyst consensus is buy with an average price target of $218.76. Rallies surfaces BIIB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate BIIB?

26 analysts cover BIIB: 0 strong buy, 15 buy, 10 hold, 1 sell, and 0 strong sell. The consensus rating is buy. The average price target is $218.76.

BIIB Key Metrics

Key financial metrics for BIIB
Metric	Value
Price	$187.75
Market Cap	$28.33B
P/E Ratio	20.20
EPS	$9.35
Dividend Yield	0.00%
52-Week High	$205.97
52-Week Low	$110.04
Volume	668.76K
Avg Volume	0
Revenue (TTM)	$9.94B
Net Income	$1.37B
Gross Margin	75.49%

BIIB Analyst Consensus

26 analysts cover BIIB: 0 strong buy, 15 buy, 10 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $218.76.

Latest BIIB News

Biogen Acquires Apellis for $5.3B and Advances Tau Drug, Shares Jump 10% — May 15, 2026
Biogen drops after Phase 2 CELIA diranersen data, despite plan for Phase 3 — May 14, 2026
Biogen Completes $41-Per-Share Apellis Acquisition While Alzheimer’s Drug Misses Primary Endpoint — May 14, 2026
Biogen’s Apellis Acquisition Spurs SmallCap 600 Removal on May 14 — May 7, 2026
Bright Horizons, Remitly Join S&P SmallCap 600 as Apellis and Tri Pointe Exit — May 7, 2026

Recent BIIB Insider Trades

Murphy Nicole bought 3 (~$585.105) on Feb 12, 2026.
Singhal Priya sold 2.66K (~$531.55K) on Feb 9, 2026.
Singhal Priya sold 748 (~$134.12K) on Feb 2, 2026.

Common questions about BIIB

What do analysts rate BIIB?: 26 analysts cover BIIB: 0 strong buy, 15 buy, 10 hold, 1 sell, and 0 strong sell. The consensus rating is buy. The average price target is $218.76.
Does Rallies show BIIB price targets?: Yes. Rallies tracks BIIB analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is BIIB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BIIB. It does not provide personalized investment advice.